Helland Å - Search Results

1

Clinicopathological characteristics of 11 NSCLC patients with EGFR-exon 20 mutations.

Lund-Iversen M, Kleinberg L, Fjellbirkeland L, Helland Å, Brustugun OT. Lund-Iversen M, et al. Among authors: helland a. J Thorac Oncol. 2012 Sep;7(9):1471-3. doi: 10.1097/JTO.0b013e3182614a9d. J Thorac Oncol. 2012. PMID: 22895145 Free article.

2

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival.

Wang Y, Helland A, Holm R, Skomedal H, Abeler VM, Danielsen HE, Tropé CG, Børresen-Dale AL, Kristensen GB. Wang Y, et al. Among authors: helland a. Br J Cancer. 2004 Feb 9;90(3):678-85. doi: 10.1038/sj.bjc.6601537. Br J Cancer. 2004. PMID: 14760384 Free PMC article.

3

[Lung cancer in smokers and never-smokers].

Helland A, Brustugun OT. Helland A, et al. Tidsskr Nor Laegeforen. 2009 Sep 24;129(18):1859-62. doi: 10.4045/tidsskr.08.0652. Tidsskr Nor Laegeforen. 2009. PMID: 19844277 Free article. Review. Norwegian.

4

Excessive Soft Tissue Reaction after Stereotactic Body Radiation Therapy in a Woman with Four Different Cancer Diagnoses.

Turzer M, Brustugun OT, Helland A. Turzer M, et al. Among authors: helland a. Case Rep Oncol. 2010 Jun 26;3(2):195-201. doi: 10.1159/000317104. Case Rep Oncol. 2010. PMID: 20740196 Free PMC article.

5

Sex-specific trends in lung cancer incidence and survival: a population study of 40,118 cases.

Sagerup CM, Småstuen M, Johannesen TB, Helland Å, Brustugun OT. Sagerup CM, et al. Among authors: helland a. Thorax. 2011 Apr;66(4):301-7. doi: 10.1136/thx.2010.151621. Epub 2011 Jan 2. Thorax. 2011. PMID: 21199818

6

Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity.

Turzer M, Brustugun OT, Waldeland E, Helland A. Turzer M, et al. Among authors: helland a. Case Rep Oncol. 2011 Jan 21;4(1):25-34. doi: 10.1159/000324113. Case Rep Oncol. 2011. PMID: 21526003 Free PMC article.

7

EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery.

Helland Å, Skaug HM, Kleinberg L, Iversen ML, Rud AK, Fleischer T, Sagerup C, Solberg S, Jørgensen L, Ariansen S, Brustugun OT. Helland Å, et al. J Thorac Oncol. 2011 May;6(5):947-50. doi: 10.1097/JTO.0b013e31820db209. J Thorac Oncol. 2011. PMID: 21623266 Free article.

8

Palmar bullous blistering induced by erlotinib.

Berg A, Brustugun OT, Lund-Iversen M, Helland Å. Berg A, et al. Among authors: helland a. J Thorac Oncol. 2011 May;6(5):954. doi: 10.1097/JTO.0b013e318211136b. J Thorac Oncol. 2011. PMID: 21623268 Free article. No abstract available.

9

Dynamic respiratory gated (18)FDG-PET of lung tumors - a feasibility study.

Knudtsen IS, Rødal J, Brustugun OT, Helland Å, Skretting A, Malinen E. Knudtsen IS, et al. Among authors: helland a. Acta Oncol. 2011 Aug;50(6):889-96. doi: 10.3109/0284186X.2011.583266. Acta Oncol. 2011. PMID: 21767189

10

Increasing age and carcinoma not otherwise specified: a 20-year population study of 40,118 lung cancer patients.

Sagerup CM, Småstuen M, Johannesen TB, Helland A, Brustugun OT. Sagerup CM, et al. Among authors: helland a. J Thorac Oncol. 2012 Jan;7(1):57-63. doi: 10.1097/JTO.0b013e3182307f7e. J Thorac Oncol. 2012. PMID: 21900838 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters